J. Welsh

Joe Y. Chang, D. Gomez, J. Welsh, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled Trials.

J. Lee, D. Gomez, J. Welsh, 2017, International journal of radiation oncology, biology, physics.

A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors

Joe Y. Chang, Charles R. Thomas, C. Simone, 2018, Journal of Immunotherapy for Cancer.

Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy.

D. Gomez, J. Welsh, R. Komaki, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Cost Analysis of PET/CT Versus CT as Surveillance for Stage III Non–Small‐Cell Lung Cancer After Definitive Radiation Therapy

D. Gomez, J. Welsh, Z. Liao, 2018, Clinical lung cancer.

Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017

Charles R. Thomas, P. Spellman, P. Okunieff, 2018, Clinical Cancer Research.

Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer

Joe Y. Chang, A. Garden, C. Fuller, 2020, Head & neck.

Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure.

D. Gomez, J. Welsh, P. Balter, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab

J. Welsh, D. Schwartz, L. Mayo, 2019, Front. Oncol..

Bone morphogenetic protein 7 promotes resistance to immunotherapy

G. Calin, J. Welsh, P. Hwu, 2020, Nature Communications.

Definitive Management of Presumed Synchronous Early-Stage Non-Small Cell Lung Cancers: Outcomes and Utility of Stereotactic Ablative Radiotherapy.

Joe Y. Chang, J. Welsh, J. Heymach, 2020, International journal of radiation oncology, biology, physics.

Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung Cancer.

Joe Y. Chang, K. Hess, J. Welsh, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Prognostic significance of EGFR and KRAS mutations in NSCLC patients with brain metastases treated with radiosurgery†.

P. Brown, J. Welsh, P. Allen, 2015, Journal of radiosurgery and SBRT.

Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial

Joe Y. Chang, K. Hess, J. Welsh, 2020, Journal for ImmunoTherapy of Cancer.

Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors

A. Jimeno, J. Welsh, J. Grilley-Olson, 2020, Journal for ImmunoTherapy of Cancer.

Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity

J. Welsh, K. He, M. Cortez, 2020, Translational oncology.

Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes.

D. Gomez, J. Welsh, R. Komaki, 2014, International journal of radiation oncology, biology, physics.

Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses

J. Welsh, M. Quigley, M. Caetano, 2019, Clinical Cancer Research.

Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity.

Joe Y. Chang, D. Gomez, J. Welsh, 2017, Practical radiation oncology.

Impact of Corticosteroid Administration on Outcomes Following Stereotactic Ablative Radiotherapy for Non-small-cell Lung Cancer.

Joe Y. Chang, D. Gomez, J. Welsh, 2019, Clinical lung cancer.

Cardiac ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapy.

Joe Y. Chang, G. Gladish, D. Gomez, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Predicting 5-Year Progression and Survival Outcomes for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Ablative Radiotherapy: Development and Validation of Robust Prognostic Nomograms.

Joe Y. Chang, J. Welsh, H. Bahig, 2020, International journal of radiation oncology, biology, physics.

Considerations for Clinical Trials Testing Radiotherapy Combined With Immunotherapy for Metastatic Disease.

Joe Y. Chang, Irwin I. Tendler, J. Welsh, 2021, Seminars in radiation oncology.

Lobectomy, sublobar resection, and stereotactic radiation for early-stage non-small cell lung cancers in the elderly.

Joe Y. Chang, S. Shirvani, Jing Jiang, 2014 .

Outcome of Trimodality-Eligible Esophagogastric Cancer Patients Who Declined Surgery after Preoperative Chemoradiation

J. Ajani, J. Welsh, S. Swisher, 2012, Oncology.

Use of Multi-Site Radiation Therapy for Systemic Disease Control

Joe Y. Chang, J. Welsh, P. Balter, 2021, International Journal of Radiation Oncology*Biology*Physics.

Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation–Related Abscopal Responses

Joe Y. Chang, K. Hess, D. Gomez, 2019, Cancer Immunology Research.

Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials.

Joe Y. Chang, J. Welsh, Steven H. Lin, 2020, The Lancet. Respiratory medicine.

Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy.

J. Welsh, M. Cortez, V. Verma, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Absolute Lymphocyte Count Predicts Abscopal Responses and Outcomes in Patients Receiving Combined Immunotherapy and Radiotherapy: A prospective-retrospective analysis of 3 phase I/II Trials.

J. Welsh, M. Cortez, V. Verma, 2020, International journal of radiation oncology, biology, physics.

IDO1 Inhibition Overcomes Radiation-Induced "Rebound Immune Suppression" by Reducing Numbers of IDO1-Expressing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.

J. Welsh, Xiaohong Wang, M. Caetano, 2019, International journal of radiation oncology, biology, physics.

Anti-glucocorticoid-induced Tumor Necrosis Factor–Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal Effects

J. Welsh, M. Caetano, M. Cortez, 2018, Front. Immunol..

Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer.

J. Welsh, Steven H. Lin, R. Komaki, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy.

D. Gomez, J. Welsh, Steven H. Lin, 2017, International journal of radiation oncology, biology, physics.

Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials

J. Welsh, M. Cortez, Chunxiao Guo, 2020, Journal for ImmunoTherapy of Cancer.

Toxicity of radiation and immunotherapy combinations

J. Welsh, Chad Tang, V. Verma, 2018, Advances in radiation oncology.

Safety of Combined Immunotherapy and Thoracic Radiation Therapy: Analysis of 3 Single-Institutional Phase I/II Trials.

J. Welsh, Chad Tang, V. Verma, 2018, International journal of radiation oncology, biology, physics.

Hematologic variables associated with brain failure in patients with small-cell lung cancer.

J. Welsh, Steven H. Lin, R. Komaki, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma

J. Welsh, D. Hong, M. Caetano, 2020, Journal for ImmunoTherapy of Cancer.

Author's view: radiation and immunotherapy as systemic therapy for solid tumors

J. Welsh, Chad Tang, S. Seyedin, 2015, Oncoimmunology.

Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial.

C. Fuller, J. Welsh, R. Komaki, 2019, JAMA oncology.

Association of Medicaid Insurance With Survival Among Patients With Small Cell Lung Cancer

Joe Y. Chang, C. Fuller, J. Welsh, 2020, JAMA network open.

Chemotherapy Versus Autologous Stem-Cell Transplantation for the Treatment of Transformed Follicular Lymphoma in the Rituximab Era

P. Brown, S. McGovern, J. Welsh, 2013 .

Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer

C. Fuller, J. Welsh, R. Komaki, 2018, JAMA oncology.

Radiation and Anti-Cancer Vaccines: A Winning Combination

J. Welsh, M. Cortez, H. Barsoumian, 2018, Vaccines.

Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti–PD1-Resistant Lung Tumor Model

Joe Y. Chang, D. Gomez, J. Welsh, 2018, Clinical Cancer Research.

Investigation of PARP1 as a therapeutic target in small cell lung cancer.

J. Weinstein, K. Coombes, Jing Wang, 2012 .

Simultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma

J. Welsh, Zhengfei Zhu, X. Fu, 2014, Strahlentherapie und Onkologie.

Clinical Staging of Patients with Early Esophageal Adenocarcinoma: Does FDG-PET/CT Have a Role?

J. Ajani, J. Welsh, S. Swisher, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells.

W. Woodward, J. Welsh, Xiaohong Wang, 2018, Cancer letters.

Celebrate or calibrate? We say calibrate.

J. Ajani, J. Welsh, S. Swisher, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Overview of ongoing clinical trials investigating combined radiotherapy and immunotherapy.

J. Welsh, M. Caetano, V. Verma, 2018, Immunotherapy.

Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy.

Joe Y. Chang, D. Gomez, J. Welsh, 2017, Cancer research.

High Plus Low Dose Radiation Strategy in Combination with TIGIT and PD1 Blockade to Promote Systemic Antitumor Responses

J. Welsh, K. He, M. Cortez, 2022, Cancers.

Sensitization of a Glioblastoma Multiforme (GBM) Cell Line by MP470: A Novel c-Met Antagonist

J. Welsh, D. Bearss, D. Mahadevan, 2007 .

Radiotherapy plus immune checkpoint blockade in PD(L)-1-resistant metastatic NSCLC.

Joe Y. Chang, J. Welsh, S. Formenti, 2022, The Lancet. Oncology.

High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: results of a phase II trial.

Joe Y. Chang, J. Welsh, Ying Yuan, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Use of simultaneous radiation boost achieves high control rates in patients with non-small-cell lung cancer who are not candidates for surgery or conventional chemoradiation.

Joe Y. Chang, D. Gomez, J. Welsh, 2015, Clinical lung cancer.

Phase II trial of erlotinib and radiotherapy following chemoradiotherapy for patients with stage III non-small cell lung cancer.

I. Wistuba, J. Lee, J. Welsh, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Twice‐daily Thoracic Radiotherapy for Limited‐stage Small‐cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis

J. Welsh, Steven H. Lin, R. Komaki, 2018, Clinical lung cancer.

Randomized phase I/II trial of pembrolizumab with and without radiotherapy for metastatic non-small cell lung cancer.

Joe Y. Chang, K. Hess, J. Welsh, 2019, Journal of Clinical Oncology.

Safety and effectiveness of vascular endoprosthesis for malignant superior vena cava syndrome

J. Welsh, V. Vinh-Hung, N. Nguyen, 2009, Thorax.

Circulating microRNAs as noninvasive biomarkers in breast cancer.

G. Calin, J. Welsh, M. Cortez, 2012, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Serum inflammatory miRNAs predict radiation esophagitis in patients receiving definitive radiochemotherapy for non-small cell lung cancer.

Q. Wei, D. Gomez, J. Welsh, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Role of Mitochondria in Cancer Immune Evasion and Potential Therapeutic Approaches

J. Welsh, K. He, Aarthi Narayanan, 2020, Frontiers in Immunology.

The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells

J. Welsh, D. Bearss, L. Cooke, 2009, Radiation oncology.

A mathematical model for the quantification of a patient’s sensitivity to checkpoint inhibitors and long-term tumour burden

G. Calin, V. Cristini, J. Welsh, 2020, Nature biomedical engineering.

Strategies for combining immunotherapy with radiation for anticancer therapy.

Joe Y. Chang, D. Gomez, J. Welsh, 2015, Immunotherapy.

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumor cell PD-L1 expression and intratumoral immunosuppression

Lixia Diao, F. Xiao-Feng Qin, Gordon Robertson, 2014, Nature Communications.

PDL1 Regulation by p53 via miR-34

G. Calin, K. Kelnar, D. Gomez, 2015, Journal of the National Cancer Institute.

Modulation of c‐Met signaling and cellular sensitivity to radiation

J. Welsh, R. Komaki, A. Amini, 2013, Cancer.

Altered cancer metabolism in mechanisms of immunotherapy resistance

J. Welsh, M. Caetano, M. Cortez, 2019, Pharmacology & therapeutics.

Role of miRNAs in immune responses and immunotherapy in cancer

G. Calin, J. Welsh, S. Anfossi, 2019, Genes, chromosomes & cancer.

Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy

J. Welsh, J. Erasmus, D. Hong, 2019, Journal of Immunotherapy for Cancer.

Translational Research and Immunotherapy in Lung Cancer

D. Gomez, J. Welsh, Z. Liao, 2016 .

Glycosylation and Antitumor Immunity.

J. Welsh, T. R. Cushman, Alexandra P. Cadena, 2019, International review of cell and molecular biology.

Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation.

J. Welsh, Y. Li, M. Cortez, 2007, Translational lung cancer research.

Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer

Boris Sepesi, Joe Y. Chang, Laurence Court, 2018, Scientific Reports.

Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer.

Joe Y. Chang, K. Hess, J. Ajani, 2019, JAMA oncology.

Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer.

G. Calin, J. Welsh, R. Komaki, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery.

Joe Y. Chang, J. Roth, J. Welsh, 2021, The Lancet. Oncology.

Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study.

J. Lee, D. Gomez, J. Welsh, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma.

Russ Hamilton, Vincent Vinh-Hung, Linda Garland, 2008, Cancer treatment reviews.

Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling

R. Sidman, S. Curley, V. Cristini, 2021, medRxiv.

Targeting the c‐Met Kinase

J. Welsh, D. Hong, Chad Tang, 2015 .

Adding Erlotinib to Chemoradiation Improves Overall Survival but not Progression-Free Survival in Stage III Non-Small-Cell Lung Cancer

Diane D. Liu, W. Hong, I. Wistuba, 2015, International journal of radiation oncology, biology, physics.

Safety and Efficacy of Stereotactic Body Radiation Therapy for Locoregional Recurrences After Prior Chemoradiation for Advanced Esophageal Carcinoma

J. Welsh, D. Berg, B. Allen, 2020, Frontiers in Oncology.

Mathematical prediction of clinical outcomes in advanced cancer patients treated with checkpoint inhibitor immunotherapy

Vittorio Cristini, Eugene J. Koay, Joseph D. Butner, 2020, Science Advances.

Radiation therapy and immunotherapy: what is the optimal timing or sequencing?

J. Welsh, K. Aziz, H. Barsoumian, 2018, Immunotherapy.

Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy.

M. McCarter, J. Welsh, W. Franklin, 2009, International journal of radiation oncology, biology, physics.

Immunotherapy combined with high- and low-dose radiation to all sites leads to complete clearance of disease in a patient with metastatic vaginal melanoma.

J. Welsh, S. Patel, P. Nagarajan, 2021, Gynecologic oncology.

Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment

Joe Y. Chang, J. Welsh, S. Hahn, 2019, Front. Immunol..

Incidence of Second Malignancy after Successful Treatment of Limited‐Stage Small–Cell Lung Cancer and Its Effects on Survival

J. Welsh, Steven H. Lin, R. Komaki, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Metformin use and improved response to therapy in esophageal adenocarcinoma

T. Guerrero, J. Ajani, J. Welsh, 2013, Acta oncologica.

SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti–PD-1–Resistant Model of Non–Small Cell Lung Cancer

J. Welsh, M. Cortez, V. Verma, 2020, Cancer Immunology Research.

Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control.

Betty Y. S. Kim, P. Brown, K. Hess, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Optimizing Radiotherapy with Immunotherapeutic Approaches.

Jonathan E Schoenhals, Tijana Skrepnik, Ugur Selek, 2017, Advances in experimental medicine and biology.

Preclinical Rationale and Clinical Considerations for Radiotherapy Plus Immunotherapy: Going Beyond Local Control.

Joe Y. Chang, J. Welsh, S. Hahn, 2016, Cancer journal.

Rad51 protein expression and survival in patients with glioblastoma multiforme.

J. Welsh, J. Eschbacher, Jesse D. Martinez, 2009, International journal of radiation oncology, biology, physics.

Progress in the management of limited‐stage small cell lung cancer

J. Welsh, R. Komaki, A. Amini, 2014, Cancer.

Does the timing of esophagectomy after chemoradiation affect outcome?

J. Ajani, J. Roth, J. Welsh, 2012, The Annals of thoracic surgery.

Pulsed Radiation Therapy to Improve Systemic Control of Metastatic Cancer

J. Welsh, K. He, M. Cortez, 2021, Frontiers in Oncology.

Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?

D. Gomez, J. Welsh, P. Sharma, 2014, Cancer Immunology Research.

Commercial Insurance Coverage of Advanced Radiotherapy Techniques Compared to American Society for Radiation Oncology Model Policies.

Joe Y. Chang, J. Welsh, Steven H. Lin, 2020, Practical radiation oncology.

Immunotherapy in lung cancer.

J. Welsh, A. Tsao, V. Papadimitrakopoulou, 2014, Translational lung cancer research.

Immunomodulation with Radiation

J. Welsh, S. Demaria, J. Schoenhals, 2018 .

Stereotactic Ablative Radiation Therapy Combined With Immunotherapy for Solid Tumors.

Joe Y. Chang, D. Gomez, J. Welsh, 2016, Cancer journal.

Combining Immunotherapy with Radiotherapy for the Treatment of Genitourinary Malignancies.

J. Welsh, J. Efstathiou, A. Bossi, 2019, European urology oncology.

Phase I/II Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage Small Cell Lung Cancer.

Joe Y. Chang, K. Hess, J. Welsh, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Kinetics of Intratumoral Immune Cell Activation During Chemoradiation for Cervical Cancer.

J. Welsh, A. Klopp, S. Dorta-Estremera, 2018, International journal of radiation oncology, biology, physics.

Combining radiation plus immunotherapy to improve systemic immune response.

Joe Y. Chang, D. Gomez, J. Welsh, 2018, Journal of thoracic disease.

Cancer Immunology at the Crossroads: Complementary Therapeutic Modalities Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?

D. Gomez, J. Welsh, P. Sharma, 2014 .

Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.

Joe Y. Chang, S. Shirvani, Jing Jiang, 2014, JAMA surgery.

Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer.

Jinzhong Yang, J. Welsh, R. Komaki, 2011, International journal of radiation oncology, biology, physics.

Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapy: Halvorsen AR, Helland Å, Fleischer T, et al (Oslo Univ Hosp-The Norwegian Radium Hosp, Norway; et al) Int J Cancer 135:2085-2095, 2014§

J. Welsh, S. Seyedin, 2015 .

The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States.

J. Welsh, R. Salgia, A. Amini, 2020, Clinical lung cancer.

Radiotherapy enhanced by NBTXR3 nanoparticles overcomes anti-PD1 resistance and evokes abscopal effects.

J. Welsh, S. Paris, K. He, 2021, International journal of radiation oncology, biology, physics.

Aortic dose constraints when reirradiating thoracic tumors.

M. Martel, D. Gomez, J. Welsh, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Intensity-Modulated Radiotherapy versus 3-Dimensional Conformal Radiotherapy Strategies for Locally Advanced Non-Small-Cell Lung Cancer.

J. Welsh, U. Selek, E. Topkan, 2015, Balkan medical journal.

Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study

Joe Y. Chang, J. Welsh, Steven H. Lin, 2021, Clinical and translational radiation oncology.

Validated biomarker signatures that predict pathologic response to preoperative chemoradiation therapy (CTRT) with high specificity and desirable sensitivity levels in patients with esophageal cancer (EC).

D. Berry, J. Ajani, J. Welsh, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Novel Use of Low-Dose Radiotherapy to Modulate the Tumor Microenvironment of Liver Metastases

J. Welsh, E. Koay, K. He, 2021, Frontiers in Immunology.

Impact of Incidental Cardiac Radiation on Cardiopulmonary Toxicity and Survival for Locally Advanced Non-Small Cell Lung Cancer: Reanalysis of NRG Oncology/RTOG 0617 With Centrally Contoured Cardiac Structures

P. Iyengar, J. Welsh, J. Bradley, 2016 .

Pattern of failure following chemoradiation for locally advanced non-small cell lung cancer: potential role for stereotactic body radiotherapy.

J. Welsh, N. Nguyen, L. M. Nguyen, 2010, Anticancer research.

Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults.

Joe Y. Chang, S. Shirvani, Jing Jiang, 2015, Journal of geriatric oncology.

Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer.

Joe Y. Chang, D. Gomez, J. Welsh, 2017, International Journal of Radiation Oncology, Biology, Physics.

A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer.

J. Ajani, J. Welsh, S. Swisher, 2012, European journal of cancer.

Reply to v.R. Bhatt et Al and m.C. Chamberlain.

P. Brown, S. McGovern, J. Welsh, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer.

J. Ajani, J. Welsh, S. Swisher, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis.

J. Ajani, J. Welsh, S. Swisher, 2012, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Nomograms for Prognostication of Outcome in Patients with Esophageal and Gastroesophageal Carcinoma Undergoing Definitive Chemoradiotherapy

J. Ajani, J. Welsh, S. Swisher, 2012, Oncology.

Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy

J. Ajani, J. Welsh, S. Swisher, 2011, Cancer.

Abscopal Response Rates after Salvage Radiation in Patients with Progressive Disease on Immunotherapy

J. Welsh, D. Hong, Chad Tang, 2020 .

Stereotactic ablative radiotherapy: A potentially curable approach to early stage multiple primary lung cancer

Joe Y. Chang, J. Roth, D. Gomez, 2013, Cancer.

Outcomes of re-irradiation for brain recurrence after prophylactic or therapeutic whole-brain irradiation for small cell lung Cancer: a retrospective analysis

J. Welsh, Steven H. Lin, R. Komaki, 2018, Radiation oncology.

Use of Multi-Site Radiation Therapy as Systemic Therapy: A New Treatment Approach Personalized by Patient Immune Status.

Joe Y. Chang, J. Welsh, P. Balter, 2020, International Journal of Radiation Oncology, Biology, Physics.

The Influence of Histopathologic Tumor Viability on Long-term Survival and Recurrence Rates Following Neoadjuvant Therapy for Esophageal Adenocarcinoma

J. Roth, J. Welsh, S. Swisher, 2013, Annals of surgery.

Immediately Concurrent Chemoradiation Therapy Is Associated With Improved 2-Year Overall Survival in Patients With Limited Small-Cell Lung Cancer

J. Welsh, Steven H. Lin, R. Komaki, 2016 .

Completing Thoracic Radiation Therapy With Concurrent Chemotherapy Within 6 weeks Is Important for Reducing Distant Disease in Patients With Limited-Stage Small Cell Lung Cancer

J. Welsh, Steven H. Lin, R. Komaki, 2016 .

Financial relationships between industry and principal investigators of US cooperative group randomized cancer clinical trials

Charles R. Thomas, J. Welsh, A. Amini, 2021, International journal of cancer.

Abstract 2658: Phase II study of chemoradiation therapy and erlotinib for stage III non-small cell lung cancer

I. Wistuba, J. Lee, J. Welsh, 2011 .

Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference

R. Weichselbaum, R. Timmerman, J. Welsh, 2023, Oncoimmunology.

Impact of Tumor Board Recommendations on Treatment Outcome for Locally Advanced Head and Neck Cancer

Paul Vos, Vincent Vinh-Hung, Nam P. Nguyen, 2008, Oncology.

Low-Dose Radiation Decreases Cancer-Associated Fibroblasts and May Increase T-Cell Trafficking into Tumors

J. Welsh, M. Cortez, V. Verma, 2020 .

Senolytic Cocktail Dasatinib Plus Quercetin Enhances the Antitumor Effect of Senescence-Inducing Radiotherapy in a Preclinical Model of Melanoma.

J. Welsh, M. Cortez, H. Barsoumian, 2021, International journal of radiation oncology, biology, physics.

Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trial

Betty Y. S. Kim, S. McGovern, J. Welsh, 2023, Journal for ImmunoTherapy of Cancer.

Association of clinical complete response (cCR) after preoperative chemoradiation and pathological complete response (pathCR) in patients with gastroesophageal cancer (GEC) and indispensability of trimodality therapy (TMT).

J. Ajani, J. Welsh, S. Swisher, 2012 .

Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancer.

Joe Y. Chang, S. Shirvani, D. Gomez, 2013, International journal of radiation oncology, biology, physics.

Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancer

Joe Y. Chang, J. Welsh, Steven H. Lin, 2021, Acta oncologica.

Phase 2 5-Arm Trial of Ipilimumab Plus Lung or Liver Stereotactic Radiation for Patients with Advanced Malignancies

D. Gomez, J. Welsh, R. Komaki, 2017 .

Galectin-1 and Immune Suppression during Radiotherapy

J. Welsh, S. Hahn, A. Maity, 2014, Clinical Cancer Research.

Rad51 protein expression and survival in patients with glioblastoma multiforme.

J. Welsh, J. Eschbacher, Jesse D. Martinez, 2009, International journal of radiation oncology, biology, physics.

Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy.

Joe Y. Chang, D. Gomez, J. Welsh, 2017, Cancer research.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.

NBTXR3 Radiation Enhancing Hafnium Oxide Nanoparticles Activated By Radiotherapy In Combination With Anti-PD-1 Therapy: A Phase I Study

A. Pearson, J. Welsh, J. Akulian, 2020 .

Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma.

J. Welsh, V. Vinh-Hung, N. Nguyen, 2008, Cancer treatment reviews.

Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer.

Hongliang Liu, D. Gomez, J. Welsh, 2016, Clinical lung cancer.

Phase I Trial: SABR and Ipilimumab—Response

J. Welsh, D. Hong, Chad Tang, 2017, Clinical Cancer Research.